Obsessive-Compulsive Disorders Michael Jenike, MD obsessivecompulsive Disorders. The staff of the obsessive-compulsive Disorders (OCD) Clinical and Research Unit http://neuro-www.mgh.harvard.edu/research/jenike.html
Extractions: Michael Jenike, M.D. The staff of the Obsessive-Compulsive Disorders (OCD) Clinical and Research Unit are engaged in a number of ongoing projects including an NIMH funded study to evaluate treatment outcome and predictors of response in OCD patients blindly treated with Fluoxetine, phenelzine (a monoamine oxidase inhibitor), or placebo. They are also gathering data to evaluate the longitudinal course of symptoms in OCD patients. Other ongoing trials include: separate placebo-controlled double-blind studies involving clomipramine, fluoxetine, fluvoxamine, paroxetine, sertraline, and stimulants (eg, dextroamphetamine and methylphenidate); a controlled trial of group behavior therapy in preventing relapse upon drug withdrawal; comparative neuropsychological testing of patients with OCD, Tourette's syndrome, trichotillomania, and body dysmorphic disorder (BDD). Other studies are looking at predictors of treatment outcome, personality disorders and traits in OCD patients and the impact of these concomitant diagnoses on treatment outcome, studies of computerized behavior therapy and record keeping, signal-detection studies in collaboration with Professor Stephen Kosslyn from the Department of Psychology at Harvard, and the use of augmenting pharmacologic agents in treating refractory OCD patients. Since some OCD patients are refractory to state-of-the-art treatments and remain almost totally disabled, the research group has focused on the use of neurosurgical treatments for severe and treatment-refractory patients. Studies with both cingulotomy (in collaboration with the Department of Neurosurgery at MGH) and gamma capsulotomy (in collaboration with the Department of Neurosurgery at Brown Universty and the Karolinska Institute in Sweden) are ongoing. The first double-blind controlled (ie, sham) study of a neurosurgical procedure to treat OCD has been proposed by investigators in the OCD unit, and a NIMH RO1 application has been submitted. Human subjects approval has been obtained at MGH, Brown University, and Rhode Island Hospital, and this study is now underway.
The OOCDN.ORG Website Is Currently Being Upgraded. The OOCDN.ORG website is currently being upgraded. Please please bear with us while we change. You should be automatically redirected to the old site. http://www.oocdn.org/
Extractions: Select One Contact CME? Order? Register? Place an Ad? Print Pages? Ask a Colleague? More... ADD/ADHD Alcoholism Alzheimer's Anorexia Anxiety Bipolar Disorder Borderline Bulimia Children Compulsive Dementia Depression Dissociation Drug Abuse Eating Disorders Fear Forgetfulness Hyperactivity Mania Manic-Dep Mood Disorder Narcissistic Neurology Obsessive OCD Panic Paraphilias Phobia Personality Psychosis PTSD Schizophrenia Seasonal Mood Sexual Issues Social Phobia Suicidal Tic Disorders Violence Select Your Destination> MHI Home Page MHI's Awards and Recognition About CME, Inc. CME InfoStore Help! Customer Service Online Search MHI Site Map Annual Congresses Ask the Expert Ask the Medical Expert Bipolar Disorders Information Center Classifieds Clinical Consult Clinical Consult in Bipolar Disorder Clinical Consult in Depression Clinical Consult in Dementia CME Conferences CME Home Study Catalog CME Online Courses CME Search Controversy in Medicine Poll Depression infoCenter Disorder Index Geriatric Times Healthier You The Journal (NAMI California) Medical Book Locator MEDInfoSource Mental Health Conferences MH Address Book MH Calendar MH Book Locator MH Connections - Lists, Newsgroups
Schizophrenia.com Changed Page Announcement. The page you are looking for is no longer here it may be either at the schizophrenia.com web site or http://www.schizophrenia.com/ami/diagnosis/MorSZ.html
Extractions: The page you are looking for is no longer here - it may be either at the schizophrenia.com web site or the NAMI/Metro-NYC Web site.The NAMI/Metro-NYC Web Site has moved to http://www.nami-nyc-metro.org Please change your bookmarks and links. The Schizophrenia Home Page is still at http://www.schizophrenia.com You are also invited to visit the Treatment Advocacy Center at http://www.psychlaws.org
